Downregulation of Dicer Confers Sorafenib Resistance in Hepatocellular Carcinoma Cells
碩士 === 中國醫藥大學 === 癌症生物學研究所碩士班 === 101 === Liver cancer is one of the most common cancers, and has high mortality worldwide. About 85% of liver cancer is hepatocellular carcinoma (HCC). Sorafenib is a small molecular inhibitor that targets to several tyrosine kinases and affects multiple cellular fun...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2013
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/83603253182409220464 |